Compagnie Lombard Odier SCmA’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $87K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $324K | Buy |
|
|||||
|
2023
Q3 | $260K | Hold |
|
|||||
|
2023
Q2 | $354K | Sell |
|
|||||
|
2023
Q1 | $492K | Sell |
|
|||||
|
2022
Q4 | $482K | Buy |
|
|||||
|
2022
Q3 | $508K | Buy |
|
|||||
|
2022
Q2 | $360K | Hold |
|
|||||
|
2022
Q1 | $445K | Hold |
|
|||||
|
2021
Q4 | $490K | Hold |
|
|||||
|
2021
Q3 | $428K | Hold |
|
|||||
|
2021
Q2 | $392K | Sell |
|
|||||
|
2021
Q1 | $592K | Sell |
|
|||||
|
2020
Q4 | $5.23M | Buy |
|
|||||
|
2020
Q3 | $2.98M | Buy |
|
|||||
|
2020
Q2 | $2.35M | Buy |
|
|||||
|
2020
Q1 | $1.58M | Sell |
|
|||||
|
2019
Q4 | $2.1M | Buy |
|
|||||
|
2019
Q3 | $1.51M | Buy |
|
|||||
|
2019
Q2 | $554K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $77K | Hold |
|
|||||
|
2018
Q3 | $87K | Hold |
|
|||||
|
2018
Q2 | $73K | Buy |
|
|||||
|
2018
Q1 | $35K | Sell |
|
|||||
|
2017
Q4 | $56K | Buy |
|
|||||
|
2017
Q3 | $27K | Sell |
|
|||||
|
2017
Q2 | $172K | Hold |
|
|||||
|
2017
Q1 | $137K | Sell |
|
|||||
|
2016
Q4 | $360K | Sell |
|
|||||
|
2016
Q3 | $473K | Hold |
|
|||||
|
2016
Q2 | $391K | Hold |
|
|||||
|
2016
Q1 | $346K | Sell |
|
|||||
|
2015
Q4 | $498K | Buy |
|
|||||
|
2015
Q3 | $298K | Buy |
|
|||||
|
2015
Q2 | $156K | Sell |
|
|||||
|
2015
Q1 | $343K | Sell |
|
|||||
|
2014
Q4 | $475K | Sell |
|
|||||
|
2014
Q3 | $473K | Buy |
|
|||||
|
2014
Q2 | $196K | Hold |
|
|||||
|
2014
Q1 | $170K | Buy |
|
|||||
|
2013
Q4 | $48K | Buy |
|